Advertisement

Topics

Seegene Inc. Company Profile

22:59 EST 9th December 2018 | BioPortfolio

Seegene is the world’s leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx). Seegene’s core enabling technologies – ACP™, DPO™, READ™, TOCE™, mTOCE™ and MuDT™ - are the foundation for M-MoDx tests that can simultaneously detect multiple targets with high sensitivity, specificity and reproducibility. Seegene’s products detect multi-pathogens with great reliability and throughput, ultimately providing the most economical basis for saving time, labor and cost. Seegene’s mission is to maintain leadership in molecular diagnostics for infectious diseases, genetics, pharmacogenomics, and oncology using innovative proprietary technologies.


News Articles [9 Associated News Articles listed on BioPortfolio]

Seegene Unveils New Real-time PCR Analysis Technology, Drastically Increasing Its Multiplexing Capacity

SEOUL, South Korea, Sept. 19, 2018 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced its proprietary technology, "MuCT™". This is...

Seegene launches a new anti-microbial drug resistance test kit, replacing the conventional culture method

SEOUL, South Korea, Nov. 26, 2018 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR assays, announced that multi-site clinical trials for measuring clinical perf...

Seegene Inc 096530 Product Pipeline Analysis, 2018 Update [Report Updated: 04102018] Prices from USD $750

SummarySeegene Inc Seegene is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO,...

Seegene Inc 096530 Medical Equipment Deals and Alliances Profile [Report Updated: 15102018] Prices from USD $250

SummarySeegene Inc Seegene is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO,...

Seegene Inc 096530 Medical Equipment Deals and Alliances Profile [Report Updated: 12072018] Prices from USD $250

SummarySeegene Inc Seegene is a biotechnology company that develops molecular diagnostic reagents. The company's products comprise seeplex, anyplex, and magicplex among others. It develops ACP, DPO, R...

Seegene Inc 096530 Medical Equipment Deals and Alliances Profile [Report Updated: 12062018] Prices from USD $250

SummarySeegene Inc Seegene is a biotechnology company that develops molecular diagnostic reagents. The company's products comprise seeplex, anyplex, and magicplex among others. It develops ACP, DPO, R...

2018 Top 5 HPV Testing Players in North America, Europe, AsiaPacific, South America, Middle East and Africa [Report Updated: 06062018] Prices from USD $4960

The human papillomavirus HPV test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing i...

20182023 Global HPV Testing Consumption Market Report [Report Updated: 06062018] Prices from USD $4660

In this report, LP Information covers the present scenario with the base year being 2017 and the growth prospects of global HPV Testing market for 20182023.The human papillomavirus HPV test detects th...

Drugs and Medications [0 Results]

None

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Evaluation of Seegene Allplex Respiratory Panel 1 kit for the detection of influenza virus and human respiratory syncytial virus.

Influenza (FLUV) and human respiratory syncytial (HRSV) viruses are etiological agents of respiratory infections that cause a significant morbidity and mortality worldwide. A rapid and accurate diagno...

Comparison of the Biofire FilmArray Respiratory Panel, Seegene AnyplexII RV16, and Argene for the detection of respiratory viruses.

Respiratory infections are common reasons for hospital admission, and are associated with enormous economic burden due to significant morbidity and mortality. The wide spectrum of microbial agents und...

Rapid Detection of Respiratory Pathogens for Community-Acquired Pneumonia by Capillary Electrophoresis-Based Multiplex PCR.

Community-acquired pneumonia (CAP) is a common infectious disease linked to high rates of morbidity and mortality. Fast and accurate identification of the pathogens responsible for CAP will aid in dia...

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Seegene Technologies, Inc.

Seegene is the world’s leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx). Seegene’s core enabling technologies ...

Seegene Inc.

Seegene is the world’s leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx). Seegene’s core enabling technologies ...

Seegene

More Information about "Seegene Inc." on BioPortfolio

We have published hundreds of Seegene Inc. news stories on BioPortfolio along with dozens of Seegene Inc. Clinical Trials and PubMed Articles about Seegene Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Seegene Inc. Companies in our database. You can also find out about relevant Seegene Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record